butabarbital will decrease the level or impact of levonorgestrel oral/ethinylestradiol/ferrous bisglycinate by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Closely. The efficacy of hormonal contraceptives can be decreased.
butabarbital will decrease the level or outcome of cyclosporine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
butabarbital will lower the level or impact of ramelteon by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Not known.
If you believe you or another person could have taken an overdose of this medication, get crisis assistance at the same time. Getting an overdose of butabarbital or using Alcoholic beverages or other CNS depressants with butabarbital might produce severe breathing complications and unconsciousness.
Butabarbital sodium is usually a Schedule III managed compound while in the US and Canada as a consequence of hazard of abuse and dependence. A psychoactive compound, butabarbital drugs are often abused with chance of acute intoxication and habit.
butabarbital will decrease the extent or effect of budesonide by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
butabarbital will decrease the extent or result of theophylline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
butabarbital will reduce the extent or outcome of donepezil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unidentified.
fentanyl iontophoretic transdermal procedure and butabarbital each increase sedation. Stay clear of or Use Alternate Drug. Restrict use to people for whom option cure choices are inadequate
butabarbital will lessen the extent or outcome of nimodipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Mysterious.
butabarbital will lessen the extent or influence of etoposide by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
Overview your financial assist deal by logging in to the myHeliotrope account using your new get more info Purchase e mail.
butabarbital will decrease the level or result of ivosidenib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Coadministration of ivosidenib with sturdy CYP3A4 inducers reduced ivosidenib plasma concentrations.
Usage of suvorexant with Alcoholic beverages is just not advisable, and the use of suvorexant with some other drug to treat sleeplessness will not be recommended. Consider therapy modification